Wnt5a, expressed by inflammatory fibroblasts under hypoxic conditions, reinforces tumor angiogenesis suppression through VEGFR1 (Flt1)-dependent pathways and sustains a hypoxic niche that drives epiregulin production thereby potentiating tumor growth and metastasis (37). The gene discussed is WNT5A; the disease is neoplasm.